Latest News

A 25% fee on every sale, zero China revenue just months ago, and a stock still down 7% this year. Is China's reopening a real catalyst or a trap?

The pharmaceutical giant still has plenty of work to do to recover from recent woes.

Despite Tesla's many achievements, the company appears to be falling behind in a key future business that's helping prop up its stock price.

This ETF tracks a global index of clean energy companies, offering diversified exposure to renewable energy and related technologies.

It's not a name usually known for market leadership, but it certainly makes sense right now.

The flash memory specialist was riding Micron's coattails.

The artificial intelligence (AI) boom has been a powerful engine for the stock market, rewarding investors who targeted the companies building its foundation. Yet a sudden, sharp selloff recently hit the semiconductor sector, with industry leaders like Micron (NASDAQ: MU) and Western Digital (NASDAQ: WDC) seeing declines from their recent highs. This downturn was not triggered by a weak earnings report or a cut in guidance, but by what seemed like good news: a technology breakthrough from Alphabet’s (NASDAQ: GOOGL) Google.

New executive pay packages will reward top officers for pushing the share price higher.

Rising oil prices and geopolitical uncertainty are taking a sledgehammer to the major indexes.

Norwegian could be a market-beating turnaround story, despite the risks.

It might be a great time to invest in these companies even as many investors are reducing their positions.

SoundHound just revealed a new AI system, but the stock still fell. Here's why that disconnect could matter much more than investors realize.

Elon Musk has never shied away from setting the bar high. Here is how investors should approach the looming blockbuster IPO.

The markets continue to react to political rhetoric, but the current reality favors buying energy stocks.

What Happened? Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 4.7% in the afternoon session after the FDA approved Foundayo (orforglipro...

What Happened? A number of stocks jumped in the afternoon session after investor sentiment turned positive on hopes of a potential ceasefire in Iran, which a...

What Happened? A number of stocks jumped in the afternoon session after investor sentiment turned positive on hopes of a potential ceasefire in Iran, which a...

What Happened? A number of stocks fell in the afternoon session after signals of de-escalation in the U.S.-Iran conflict caused oil prices to fall, removing ...